Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS • Currently down 0.07 (-0.08%) in today's trading session

1 member of Congress has disclosed 3 trades in Crinetics Pharmaceuticals, Inc. (CRNX) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 3 March 2026. Aggregate disclosed activity totals roughly $24K in purchases (midpoint estimates from bracketed disclosure amounts).

Crinetics Pharmaceuticals, Inc. is currently trading at $83.65, positioned at 99% of its 52-week range ($25.83 – $84.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$83.65
24h Change
-0.07 (-0.08%)
52 Week Range
$25.83—$84.00
View on NASDAQ

Crinetics Pharmaceuticals, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CRNX

Select to highlight on chart
3 transactions
Compliance: 100%
Gilbert Cisneros3 Mar 20267 Apr 2026PurchaseStock$1,001 - $15,000+105.63%
Gilbert Cisneros17 Apr 20256 May 2025PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros29 Jan 202511 Feb 2025PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$8.85B

Volume

4.26M

Beta

0.23

P/E Ratio

-16.31

Fundamentals

EPS

$-5.13

Div. Yield

—

Open

$83.78

Day Range

$83.64 — $83.79

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
R. Scott Struthers
IPO Date
2018-07-18
Website
www.crinetics.com

Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flags...

Earnings

Next Report

Q2 2026

4 Aug

EPS Est.

$-1.23

Rev. Est.

$14.8M

Days Until

12

Recent Quarters

Q1 20267 May
EPS$-1.23
Miss 0.8%
Q4 202526 Feb
EPS$-1.29
Beat 5.8%
Q3 20256 Nov
EPS$-1.38
Miss 8.7%
Q2 20257 Aug
EPS$-1.23
Miss 8.8%
Q1 20258 May
EPS$-1.04
Miss 5.0%
Q4 202427 Feb
EPS$-0.88
Beat 4.3%
Q3 202412 Nov
EPS$-0.96
Miss 5.4%
Q2 20248 Aug
EPS$-0.94
Miss 9.3%
Q1 20249 May
EPS$-0.93
Miss 10.7%
Q4 202328 Feb
EPS$-0.90
Miss 1.1%
Q3 20237 Nov
EPS$-1.01
Miss 13.5%
Q2 20238 Aug
EPS$-0.94
Miss 10.6%
Q1 20234 May
EPS$-0.85
Miss 3.7%
Q4 202228 Feb
EPS$-0.84
Miss 2.4%
Q3 202214 Nov
EPS$-0.78
Beat 0.0%
Q2 202212 Aug
EPS$-0.81
Miss 30.6%
Q1 202212 May
EPS$-0.73
Miss 30.4%
Q4 202130 Mar
EPS$-0.68
Miss 19.3%
Q3 20215 Nov
EPS$-0.73
Miss 4.3%
Q2 202110 Aug
EPS$-0.70
Miss 16.7%
Q1 20216 May
EPS$-0.69
Miss 6.2%
Q4 202030 Mar
EPS$-0.66
Miss 13.8%
Q3 20206 Nov
EPS$-0.56
Miss 7.7%
Q2 20207 Aug
EPS$-0.53
Miss 1.9%
Q1 20208 May
EPS$-0.71
Miss 12.7%
Q4 20199 Mar
EPS$-0.60
Beat 10.4%
Q3 201912 Nov
EPS$-0.60
Miss 11.1%
Q2 201913 Aug
EPS$-0.51
Miss 13.3%
Q1 201913 May
EPS$-0.37
Beat 5.1%
Q4 201813 Mar
EPS$-0.35
Beat 10.3%
Q3 201813 Nov
EPS$-0.38
Miss 11.8%
Q2 201830 Aug
EPS$-2.41
Miss 731.0%
Q2 201818 Jul
EPS$-0.25
Q3 201731 Dec
EPS$-0.18
Q2 201730 Sept
EPS$-0.17
Q1 201730 Jun
EPS$-0.12
Q4 201631 Mar
EPS$-0.19

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

AAPL

Apple Inc.

22
$321.66-4.23 (-1.30%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

WBI

WaterBridge Infrastructure LLC

17
$35.54-0.67 (-1.85%)
Energy
Held by same politician
1 politician
View Stock

SPY

State Street SPDR S&P 500 ETF Trust

17
$738.18-9.23 (-1.23%)
Financial Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about CRNX

Which members of Congress have traded CRNX?
1 member of Congress has disclosed 3 trade in Crinetics Pharmaceuticals, Inc. (CRNX) under the STOCK Act: Gilbert Cisneros.
When was CRNX most recently disclosed by Congress?
The most recent CRNX disclosure was a purchase by Gilbert Cisneros on 3 March 2026.
What is the total disclosed congressional trading volume for CRNX?
Members of Congress have disclosed approximately $24K in CRNX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in CRNX?
This CRNX page updates as soon as new STOCK Act disclosures are filed for Crinetics Pharmaceuticals, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.